Ingevity Corporation

NYSE:NGVT

Chemicals - Specialty

Basic Materials
$58.31 +1.13%

+$0.81 today

Market cap
$1.97B
Beta
1.19
P/E (TTM)
-20.0
EPS (TTM)
-$3.62
52W Low $39.74High $79.29

Volume 0.37M

Average 0.26M

NGVT Total Equity

Shareholders' claim on the company's assets after all liabilities: total assets minus total liabilities.

Ingevity CorporationNYSE: NGVT

Total Equity · Q3 FY2026 · quarter ended Sep 2026

Total equity falls 54.4% from a year ago

Total equity stood at $63M at the end of Q3 FY2026, down 54.4% from a year earlier and up 34.3% from the prior quarter. Over 3 fiscal years it compounded at -65.1% a year.

Context

  • Total equity amounted to 4.2% of total assets at the end of Q3 FY2026, down 3.3 pp from a year earlier.
  • Total equity increased in 0 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether total equity keeps falling in the next quarterly balance sheet after a -54.4% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterSep 2026
$63M+34.3% QoQ
Last fiscal yearDec 2025
$29.7M-84.8% YoY
Year agoSep 2025
$138.1M-54.4% since
Total Equity past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-54.4%——
1 year-84.8%——
3-year CAGR-65.1%——
5-year CAGR——
10-year CAGR——

Total Equity history

USD · from the balance sheet

Latest · FY2025
29.7M USD
Year-over-year change
-84.8%
4-year CAGR
-54.2%

Total Equity vs competitors

How NGVT compares with its peers on the latest reported figures

  • Peers report in different currencies, so total equity is compared through growth and share of total assets rather than absolute size.
  • Its year-over-year change of -54.4% is the 9th highest of 11, against a peer median of +3.7%.
  • Total equity amounts to 4.2% of total assets for NGVT, versus a peer median of 34.7%.
NGVT Competitors
Total Equity for NGVT and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
ASHAshland Inc.Jun 2026$1.87B USD-1.0%-16.1%40.8%
FMCFMC CorporationMar 2026$1.85B USD-58.1%-14.9%19.6%
MTXMinerals Technologies Inc.Apr 2026$1.76B USD+7.8%+2.7%50.8%
OLNOlin CorporationJun 2026$1.71B USD-13.9%-9.7%23.0%
KWRQuaker Chemical CorporationSep 2026$1.42B USD+3.7%+2.5%48.6%
IOSPInnospec Inc.Jun 2026$1.35B USD+3.8%+8.6%73.2%
ELVRElevra Lithium LimitedJun 2026A$1.05B AUD+120.8%+5.9%76.8%
AAUCAllied Gold CorporationJun 2026$626.6M USD+36.3%+65.5%28.5%
SKESkeena Resources LimitedSep 2026CA$139.82M CAD+64.0%+5.0%7.1%
NGVTIngevity CorporationSep 2026$63M USD-54.4%-65.1%4.2%
CCThe Chemours CompanyJun 2026-$48M USD-120.1%-39.0%0.7%
Peer median (excluding NGVT) —+3.7%+2.6%34.7%

Competitors are the stored peer set for NGVT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents275.4M76.7M95.9M68M78.1M
Short-term Investments00000
Net Receivables191.4M249.3M211M162.7M157.8M
Inventory241.2M335M308.8M195.9M186M
Other Current Assets7.1M12.5M33.4M58.8M23.6M
Total Current Assets724.9M683.3M658.6M493.2M454.2M
Property, Plant & Equipment (Net)772.1M855.2M829.3M687.6M637.6M
Goodwill442M518.5M527.5M175.2M4.3M
Intangible Assets378.7M455.8M385.3M323.9M215.5M
Long-term Investments35.3M109.8M99.2M87.3M83.1M
Tax Assets6.8M5.7M11.6M117.9M117M
Other Non-current Assets109.2M108.2M111.8M137.5M139.4M
Total Non-current Assets1.74B2.05B1.96B1.53B1.2B
Total Assets2.47B2.74B2.62B2.02B1.65B
Account Payables125.8M174.8M158.4M94.5M92M
Short-term Debt19.6M900K84.4M61.3M47.1M
Tax Payables14.4M8.9M16.7M5.6M0
Deferred Revenue00000
Other Current Liabilities1.1M6.9M15.1M500K14.7M
Total Current Liabilities268.9M303.5M362.9M264.1M341.3M
Long-term Debt1.25B1.47B1.38B1.24B1.06B
Deferred Tax Liabilities114.6M106.5M70.9M56.2M57.3M
Deferred Revenue (Non-current)00000
Other Non-current Liabilities125.5M114.9M126.7M130.6M39M
Total Non-current Liabilities1.53B1.73B1.63B1.56B1.28B
Total Liabilities1.8B2.04B1.99B1.83B1.62B
Common Stock400K400K400K400K400K
Retained Earnings796.1M1.01B1B572M404.9M
Accumulated OCI13.1M(46.8M)(26.7M)(41.4M)500K
Other Stockholders Equity00000
Minority Interest00000
Total Equity673.8M698.3M631.4M195.2M29.7M
Total Debt1.32B1.53B1.53B1.45B1.24B
Net Debt1.05B1.45B1.44B1.39B1.16B

Ingevity Corporation

NYSE:NGVT

Intrinsic Alpha fair value

Locked

Current Price

$58.31

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.